Exact Sciences Equity 2024

Exact Sciences Aktienanalyse

What does Exact Sciences do?

Exact Sciences Corp is a US-based company specializing in the development, manufacturing, and marketing of diagnostics. It was founded in 1995 by Kevin T. Conroy and is headquartered in Madison, Wisconsin. The company's main focus is on cancer diagnostics. It has developed an innovative test called the Cologuard test, which is a simple, non-invasive method for detecting colorectal cancer. The test can provide accurate results by analyzing a stool sample from the patient. The Cologuard test is FDA approved and recommended by physicians in the US. Exact Sciences has also developed an extensive portfolio of liquid biopsy tests, which can help detect cancer in its early stages by identifying changes in the patient's blood. The company aims to expand its position in the market for non-invasive cancer diagnostics. Originally founded as an oncology diagnostics company specializing in the development of tests for early tumor detection, Exact Sciences expanded its focus to colorectal cancer diagnostics in 2009 after acquiring the rights to a patented biomarker. The company has experienced rapid growth in recent years and has become a leader in the field of non-invasive cancer diagnostics. It has made several acquisitions, including the acquisition of Genomic Health, a provider of cancer diagnostics and molecular tests. Exact Sciences is divided into two business segments: 1. Diagnostics Exact Sciences develops and distributes diagnostics for the detection of various forms of cancer. The company has a range of products on the market, including: - Cologuard: A test for detecting colorectal cancer - Oncotype DX: A test for detecting various types of breast cancer - Oncotype MAP: A test for detecting colorectal and gastric cancer - Oncotype IQ: A platform for detecting various types of cancer 2. Research and Development Exact Sciences also conducts research and development in the field of cancer diagnostics. The company is working on developing tests for detecting many types of cancer in their early stages. It has also formed partnerships with other companies and organizations to support its research in this field. In conclusion, Exact Sciences Corp is an innovative company specializing in the development of diagnostics for the detection of various types of cancer. The company has achieved a strong market position in non-invasive cancer diagnostics and aims to further expand its product range. With the Cologuard test and its other diagnostics, the company has saved many lives and will continue to contribute to the early detection and treatment of cancer in the future. Exact Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Exact Sciences's Equity

Exact Sciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Exact Sciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Exact Sciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Exact Sciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Exact Sciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Exact Sciences Stock

What is the equity of Exact Sciences this year?

Exact Sciences has equity of 3.15 B USD this year.

What was the equity of Exact Sciences compared to the previous year?

The equity of Exact Sciences has increased/decreased by 3.36% increased compared to the previous year.

What impact does a high equity have on investors of Exact Sciences?

A high equity is advantageous for investors of Exact Sciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Exact Sciences?

A low equity can be a risk for investors of Exact Sciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Exact Sciences affect the company?

An increase in equity of Exact Sciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Exact Sciences affect the company?

A reduction in equity of Exact Sciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Exact Sciences?

Some factors that can affect the equity of Exact Sciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Exact Sciences so important for investors?

The equity of Exact Sciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Exact Sciences take to change the equity?

To change equity, Exact Sciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Exact Sciences pay?

Over the past 12 months, Exact Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Exact Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Exact Sciences?

The current dividend yield of Exact Sciences is .

When does Exact Sciences pay dividends?

Exact Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Exact Sciences?

Exact Sciences paid dividends every year for the past 0 years.

What is the dividend of Exact Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Exact Sciences located?

Exact Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Exact Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Exact Sciences from 5/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/1/2024.

When did Exact Sciences pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Exact Sciences in the year 2023?

In the year 2023, Exact Sciences distributed 0 USD as dividends.

In which currency does Exact Sciences pay out the dividend?

The dividends of Exact Sciences are distributed in USD.